Evidence map

ReviewCells2026

Advantages of Allogeneic Mesenchymal Stem Cells as an Innovative Therapy in Patients with Endometrium Dysfunction.

Tanya N Timeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41827834